DarioHealth Net Income from 2010 to 2026
| DRIO Stock | USD 11.28 0.15 1.31% |
Net Loss | First Reported 2012-03-31 | Previous Quarter -13 M | Current Value -2.1 M | Quarterly Volatility 6.1 M |
Check DarioHealth Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DarioHealth Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9 M, Interest Expense of 82.1 K or Selling General Administrative of 24.7 M, as well as many indicators such as Price To Sales Ratio of 42.67, Dividend Yield of 0.0 or PTB Ratio of 14.02. DarioHealth financial statements analysis is a perfect complement when working with DarioHealth Corp Valuation or Volatility modules.
DarioHealth | Net Income | Build AI portfolio with DarioHealth Stock |
Evaluating DarioHealth Corp's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into DarioHealth Corp's fundamental strength.
Latest DarioHealth Corp's Net Income Growth Pattern
Below is the plot of the Net Income of DarioHealth Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in DarioHealth Corp financial statement analysis. It represents the amount of money remaining after all of DarioHealth Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is DarioHealth Corp's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DarioHealth Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (42.75 M) | 10 Years Trend |
|
Net Income |
| Timeline |
DarioHealth Net Income Regression Statistics
| Arithmetic Mean | (27,212,983) | |
| Coefficient Of Variation | (82.24) | |
| Mean Deviation | 18,700,039 | |
| Median | (17,736,000) | |
| Standard Deviation | 22,381,037 | |
| Sample Variance | 500.9T | |
| Range | 71.1M | |
| R-Value | (0.78) | |
| Mean Square Error | 213T | |
| R-Squared | 0.60 | |
| Significance | 0.0003 | |
| Slope | (3,436,871) | |
| Total Sum of Squares | 8014.6T |
DarioHealth Net Income History
Other Fundumenentals of DarioHealth Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
DarioHealth Corp Net Income component correlations
About DarioHealth Corp Financial Statements
DarioHealth Corp investors utilize fundamental indicators, such as Net Income, to predict how DarioHealth Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -38.5 M | -40.4 M | |
| Net Loss | -38.5 M | -40.4 M | |
| Net Loss | -56 M | -53.2 M | |
| Net Loss | (0.57) | (0.60) | |
| Net Income Per E B T | 1.10 | 1.09 |
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving against DarioHealth Stock
| 0.62 | ALMDT | Mediantechn | PairCorr |
| 0.37 | PHF | Pharmagest Interactive | PairCorr |
| 0.34 | AJ91 | DocCheck AG | PairCorr |
| 0.32 | FDBK | Feedback PLC Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of DarioHealth Corp Correlation against competitors. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Health Care Technology sector continue expanding? Could DarioHealth diversify its offerings? Factors like these will boost the valuation of DarioHealth Corp. Projected growth potential of DarioHealth fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DarioHealth Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (10.87) | Revenue Per Share | Quarterly Revenue Growth (0.33) | Return On Assets | Return On Equity |
DarioHealth Corp's market price often diverges from its book value, the accounting figure shown on DarioHealth's balance sheet. Smart investors calculate DarioHealth Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since DarioHealth Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between DarioHealth Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DarioHealth Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.